ライフサイエンスコーパス: sputum culture

1 ximately 20% reduction in yield from induced sputum culture.

2 plex isolates recovered from cystic fibrosis sputum culture.

3 utum smear and the clearance of organisms in sputum culture.

4 We excluded tuberculosis at screening by sputum culture.

5 microbiologically confirmed with a positive sputum culture.

6 nging drug-susceptibility patterns in serial sputum cultures.

7 etween those with and those without positive sputum cultures.

8 LAI group demonstrated at least one negative sputum culture (14 [32%] of 44 vs. 4 [9%] of 45; P = 0.0

9 ive than culture in detecting Aspergillus in sputum (culture 37%, RT-PCR 74%, and GM 46%).

10 13 specimens from TB suspects with negative sputum cultures, 7 had a positive MTBDRplus assay (3 wit

11 illance for drug-resistant tuberculosis with sputum culture and drug susceptibility testing in patien

12 m smear microscopy was compared with that of sputum culture and the Xpert MTB/RIF assay for all patie

13 Sputum cultures and antibiotic sensitivities were follow

14 eled bacillary elimination rates (BERs) from sputum cultures and calculated the percentage of lipid b

15 patients, each of whom had multiple positive sputum cultures and clinical evidence of infection.

16 neumonia in Kenyan adults to justify routine sputum culture, and that treatment with benzylpenicillin

17 who have failed treatment and have positive sputum cultures are being discharged from hospital and a

18 eference to three Mycobacterium tuberculosis sputum cultures, as compared with that of a single sputu

19 ntly associated with higher odds of positive sputum cultures at 2 months.

20 ble Haemophilus influenzae was isolated from sputum cultures at 22 of 23 monthly clinic visits.

21 The primary efficacy end point was negative sputum cultures at completion of intensive phase.

22 1 patients in the control group had negative sputum cultures at month 2 (P < .001).

23 ed pneumococcal if either sputum Gram stain, sputum culture, blood culture, or the immunochromatograp

24 ent for multidrug-resistant TB, high initial sputum culture colony count, bilateral cavitations on ch

25 fect of vitamin D supplementation on time to sputum culture conversion (p(interaction)=0.03), with en

26 The primary outcome was time to sputum culture conversion (tSCC).

27 endpoint was the proportion of patients with sputum culture conversion after 1 and 2 months of treatm

28 The rate of sputum culture conversion after 1 month of tuberculosis

29 from hospital, of whom 26 (58%) had achieved sputum culture conversion and 19 (42%) had failed treatm

30 by analyzing the association between time to sputum culture conversion and both the number of potenti

31 ata provide evidence of an early increase in sputum culture conversion and greater radiographic impro

32 Time to initial sputum culture conversion and treatment outcome.

33 gating the effect of adjunctive vitamin D on sputum culture conversion are absent.

34 We defined sputum culture conversion as two or more consecutive neg

35 Rapid sputum culture conversion at 2 months indicates the ster

36 ider these results regarding the validity of sputum culture conversion at various timepoints as an ea

37 We compared results of sputum culture conversion by moxifloxacin and control re

38 population, but it did significantly hasten sputum culture conversion in participants with the tt ge

39 Adjunctive vitamin D3 accelerated sputum culture conversion in patients with one or more m

40 moxifloxacin results in significantly higher sputum culture conversion in the first 2 months compared

41 Vitamin D3 did not influence time to sputum culture conversion in the study population overal

42 tamin D did not significantly affect time to sputum culture conversion in the whole study population,

43 Sputum culture conversion is a useful and appropriate in

44 Sputum culture conversion is often used as an early micr

45 Net sputum culture conversion occurred in 22 patients (21%)

46 We aimed to assess the validity of sputum culture conversion on solid media at varying time

47 garding whether nontuberculous mycobacterial sputum culture conversion or semiquantitative culture an

48 /L; P < 0.001) but did not influence time to sputum culture conversion overall (adjusted hazard ratio

49 Sputum culture conversion status at 2 months was signifi

50 Conversely, 6 month sputum culture conversion status had high sensitivity (9

51 with greater increases in the likelihood of sputum culture conversion than including more drugs to w

52 associated with a 36% greater likelihood of sputum culture conversion than receiving an average of a

53 Independent predictors of a longer sputum culture conversion time, using an accelerated fai

54 adiographic improvement as well as long-term sputum culture conversion to negative in this population

55 Sputum culture conversion using solid medium is the best

56 Median time to sputum culture conversion was 36.0 days in the intervent

57 Sputum culture conversion was analyzed in 780 (616 in th

58 mum combined sensitivity and specificity for sputum culture conversion was reached between month 6 an

59 ients with treatment success, median time to sputum culture conversion was significantly shorter than

60 In addition, the adjusted proportion of sputum culture conversion was similar between the daily

61 c improvement, radiographic improvement, and sputum culture conversion were not different between the

62 Thus, the overall association of sputum culture conversion with a successful outcome was

63 atients with multidrug-resistant TB achieved sputum culture conversion within 12 weeks of starting tr

64 Time to sputum culture conversion, conversion status at 6 months

65 Cavitation may lead to delayed sputum culture conversion, emergence of drug resistance,

66 act that the analysis considers only initial sputum culture conversion, not reversion or long-term re

67 r, the response to treatment is monitored by sputum culture conversion, which takes several weeks for

68 on-dependent antagonism that reduces 2-month sputum culture conversion.

69 The primary outcome of interest was initial sputum culture conversion.

70 rom initiation of antimicrobial treatment to sputum culture conversion.

71 ily had a higher proportion of patients with sputum-culture conversion (41.9%, P=0.04).

72 Delamanid was associated with an increase in sputum-culture conversion at 2 months among patients wit

73 s 100 mg of delamanid twice daily, 45.4% had sputum-culture conversion in liquid broth at 2 months, a

74 nd point was the proportion of patients with sputum-culture conversion in liquid broth medium at 2 mo

75 e primary efficacy end point was the time to sputum-culture conversion in liquid broth.

76 nthase, has been associated with accelerated sputum-culture conversion in patients with multidrug-res

77 The findings were similar with assessment of sputum-culture conversion in solid medium.

78 e use of both liquid broth and solid medium; sputum-culture conversion was defined as a series of fiv

79 Treatment outcomes were defined as 2-month sputum-culture conversion, treatment episode outcome, an

80 1 month, the proportion of patients for whom sputum culture converted to negative was 17% for the IL-

81 hout treatment was greater in subjects whose sputum cultures converted to negative by the eighth week

82 Chest radiography and sputum culture drug susceptibility testing can assist ph

83 n of patients with tuberculosis diagnosed by sputum culture during screening before antiretroviral th

84 m specimens, 458 (91.6%) had both a positive sputum culture for Mycobacterium tuberculosis and a vali

85 osis based on both WHO criteria and positive sputum culture for mycobacterium Tuberculosis.

86 Sputum culture for pre-migration screening and active re

87 Sputum cultures for two patients whose nebulizers were c

88 DNA fingerprinting analysis of serial sputum cultures from 48 patients with MDR tuberculosis a

89 Serial M. tuberculosis sputum cultures from patients diagnosed with multi-drug-

90 control regimen, age (>/=35 years), initial sputum culture grade (2+ or 3+), and male sex were signi

91 ade, days to culture positivity on agar, and sputum culture grade during subsequent tuberculosis.

92 CAP, if blood culture, induced good-quality sputum culture, Gram stain, or urinary Binax demonstrate

93 Pretransplantation sputum cultures grew Aspergillus fumigatus in seven pati

94 Improvement in sputum culture, high-resolution computed tomography (HRC

95 ominant potential pathogen was identified in sputum culture in 70 of 417 case patients (17%).

96 quencies of positive, potentially pathogenic sputum cultures in chronic obstructive pulmonary disease

97 d after >or=4 consecutive months of negative sputum cultures, in prospective macrolide treatment tria

98 including the use of DNA-based methods, for sputum culture isolates presumptively identified as B. c

99 ing MacConkey plate to the routine media for sputum culture may provide additional, clinically releva

100 Typical sputum culture methods quantitate the relative amounts o

101 Clinical information, sputum cultures, molecular typing of isolates, and immun

102 Coprimary outcomes were negative sputum culture on liquid and on solid media at completio

103 uth African adults if blood culture, induced-sputum culture or Gram stain, urine antigen test, or who

104 Patients with positive Aspergillus sputum culture or positive bronchoalvelolar lavage (BAL)

105 fined as at least three consecutive negative sputum cultures over a period of at least 3 months, was

106 ron mycotoxinivorans recovered from multiple sputum cultures over time with various clinical conseque

107 r patients were recruited, and 44 (43%) were sputum culture positive for M. tuberculosis.

108 with cystic fibrosis (CF) who had antemortem sputum cultures positive for nontuberculous mycobacteria

109 Although people with HIV frequently have sputum cultures positive for NTM, few meet a strict case

110 und in patients who had only one of multiple sputum cultures positive for NTM.

111 Among 167 patients who were sputum culture-positive at initiation of second-line the

112 rom May 2009 to January 2011, we enrolled 96 sputum culture-positive index TB cases and their 442 con

113 Individualized treatment for confirmed sputum culture-positive pulmonary multidrug-resistant TB

114 trospective cohort study among patients with sputum culture-positive tuberculosis was performed.

115 ol regimens and identified factors affecting sputum culture positivity after 2 months of treatment.

116 -3.58), less likely to convert to a negative sputum culture (PR, 0.55; 95% CI, 0.33-0.94), and had a

117 are established, it would be prudent to do a sputum culture prior to IPT where this is feasible.

118 nts, 54% on ART, had symptom screening and a sputum culture result available.

119 Treatment outcomes were conversion of sputum culture results at 2 months and time to conversio

120 The objective of this study was to evaluate sputum culture results on solid media during treatment a

121 efore receiving study drug or whose baseline sputum culture results suggested prevalent tuberculosis.

122 relation between their CT features and their sputum culture results.

123 We suggest that semiquantitative sputum culture scores can be a useful tool for evaluatin

124 Baseline semiquantitative sputum culture scores did not differ between patients wi

125 The change in sputum culture semiquantitative score from baseline to M

126 sequential isolates from 49 patients who had sputum cultures separated by at least 90 days that grew

127 UAVs on microbiological specimens, blood and sputum culture specimens were seeded with usual pathogen

128 Sputum cultures, sputum interleukin 8 and neutrophil ela

129 The primary endpoint was sputum culture status at 2 mo of treatment.

130 fampin, and pyrazinamide did not affect 2-mo sputum culture status but did show increased activity at

131 .7-fold more likely to achieve conversion of sputum culture than those whose FENO decreased (odds rat

132 eatment, and relationship with conversion of sputum culture to negative at 2 months.

133 ersion of a Mycobacterium tuberculosis (Mtb) sputum culture to negative.

134 (95%CI:10-44) in the before period converted sputum cultures to negative by 8 months following treatm

135 tently colonized with H. influenzae and that sputum cultures underestimate the frequency of colonizat

136 Sputum cultures were assessed weekly with the use of bot

137 sputum cultures were positive than when the sputum cultures were negative (7.9 versus 5.6 log10 copi

138 Gastric and sputum cultures were obtained from fifteen CF patients r

139 Sputum cultures were obtained, and individual colonies w

140 opy numbers from sputum were higher when the sputum cultures were positive than when the sputum cultu

141 MODS detected 94.0% of 1,908 positive sputum cultures, whereas Lowenstein-Jensen (LJ) culture

142 Sputum cultures, which are likely to have the highest di

143 worse for patients who did not convert their sputum culture within 2 months.

144 censing for DR tuberculosis based on 2-month sputum culture would shorten time to initial approval by

145 Four of the patients' sputum cultures yielded growth of M. kansasii within 6 t